# Centessa Pharmaceuticals: Biotechnology, Cambridge, United States

> Centessa Pharmaceuticals: Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

Source: https://millionrounds.com/startup/centessa-pharmaceuticals (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Centessa Pharmaceuticals

Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

Funding reported Last round: Post ipo equity

Biotechnology Cambridge, United States

Company summary

- **Founded:** 2021 5 years old
- **Team:** 51 51 to 200 people
- **Funding reported:** $650M in dollars
- **Last round:** Post ipo equity Apr 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Centessa Pharmaceuticals has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Centessa Pharmaceuticals raised

Funding, as reported

Reported in all **$650M** in dollars

Rounds **3**

Last round **Post ipo equity**

Last round date **Apr 2024**

Investors listed **16**

## Founders and team

From Centessa Pharmaceuticals's own website: 4 on the team.

- **Charlene Stoudt** Senior Vice President, Clinical Development Operations
- **Kerstin Schultz** Senior Vice President, Global Program Leadership
- **Karen Anderson** Chief People Officer
- **Tia Bush** Chief Technology and Quality Officer

## On 3 portfolio pages

Investors who name them

- [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital)
- [Vida Ventures](https://millionrounds.com/fund/vida-ventures-llc)
- [Oberland Capital](https://millionrounds.com/fund/oberland-capital)

Each firm lists Centessa Pharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in United States

Startups like it

- [**Sojournix** Waltham · founded 2016 *Raised*](https://millionrounds.com/company/sojournix)
- [**Receptor Life Sciences** Seattle · founded 2017 *Raised*](https://millionrounds.com/company/receptor-life-sciences)
- [**Attune Pharmaceuticals** New York · founded 2018 *Raised*](https://millionrounds.com/company/attune-pharmaceuticals)
- [**AbbVie** North Chicago · founded 2012](https://millionrounds.com/startup/abbvie-2)
- [**Grail** Menlo Park · founded 2015](https://millionrounds.com/startup/grail-3)
- [**EQRx** Cambridge · founded 2019](https://millionrounds.com/startup/eqrx)
- [**Cerevel Therapeutics** Boston · founded 2018](https://millionrounds.com/startup/cerevel-therapeutics)
- [**Royalty Pharma** New York · founded 1996](https://millionrounds.com/startup/royalty-pharma)

## Is this your company?

Add your raise, your deck and your story, and put Centessa Pharmaceuticals in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)
